Literature DB >> 3206059

Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

B S Bender1, B L Davidson, R Kline, C Brown, T C Quinn.   

Abstract

In studies aimed at defining monocyte and macrophage function in patients with human immunodeficiency virus (HIV) infection, we found impaired in vivo Fc receptor-specific clearance in 20 of 25 patients with acquired immunodeficiency syndrome (AIDS) and in five of 13 patients with AIDS-related illnesses. The in vivo function of macrophage C3 receptors was also found to be abnormal: AIDS patients had a relatively large release of cell back into the circulation, suggesting failure of macrophage phagocytosis. The antibody-dependent cell-mediated cytotoxicity of circulating mononuclear cells was significantly lower in AIDS patients than in healthy controls. Monocyte nonspecific phagocytosis and surface marker expression were intact. Defective monocyte and macrophage function is an integral part of the immunopathology of AIDS, leading to the failure to control opportunistic pathogens. Whether these defects are due to intrinsic infection of the mononuclear phagocytes with HIV or are secondary to other events in the network of HIV infection remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3206059     DOI: 10.1093/clinids/10.6.1142

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  27 in total

1.  Infection of primary human monocytes by Epstein-Barr virus.

Authors:  M Savard; C Bélanger; M Tardif; P Gourde; L Flamand; J Gosselin
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Impaired regulation of HLA-DR expression in human immunodeficiency virus-infected monocytes.

Authors:  Ling Shao; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

3.  Phagocytic function of monocytes in children with human immunodeficiency virus type 1 infection.

Authors:  G Tardei; D Duiculescu; C Capo; C C Diaconu; A Mutiu; J L Mege; C E Cernescu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 4.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

5.  The effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man.

Authors:  D S Halvorsen; J B Hansen; S Grimsgaard; K H Bønaa; P Kierulf; A Nordøy
Journal:  Lipids       Date:  1997-09       Impact factor: 1.880

6.  Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages.

Authors:  G Källenius; T Koivula; K J Rydgård; S E Hoffner; A Valentin; B Asjö; C Ljungh; U Sharma; S B Svenson
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

7.  Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120.

Authors:  S Chaturvedi; S L Newman
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

8.  Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype.

Authors:  J Trial; H H Birdsall; J A Hallum; M L Crane; M C Rodriguez-Barradas; A L de Jong; B Krishnan; C E Lacke; C G Figdor; R D Rossen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques.

Authors:  L Zhang; P J Dailey; T He; A Gettie; S Bonhoeffer; A S Perelson; D D Ho
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

Authors:  Diego A Vargas-Inchaustegui; Marjorie Robert-Guroff
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.